BRAINLIFE.ORG




Neuro-Oncology Reviews




Volume 26 Number 3
15 February 2024




Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 3, 15 February








Borni M, Abdelmouleh S, Tallah M, Blibeche H, Elouni E, Boudawara MZ.
Extra-axial desmoplastic/nodular medulloblastoma in adult mimicking cerebellar metastasis: reappraisal of this rare presentation with literature review.
Ann Med Surg (Lond). 2023 Dec 13;86(2):1124-1130. doi: 10.1097/MS9.0000000000001617. PMID: 38333306. Case report, Review. ˍ




Buccilli B, Rodriguez Molina MA, Redrovan Palomeque DP, Herrera Sabán CA, Caliwag FMC, Contreras Flores CJS, Abeysiriwardana CWJ, Diarte E, Arruarana VS, Calderon Martinez E.
Liquid Biopsies for Monitoring Medulloblastoma: Circulating Tumor DNA as a Biomarker for Disease Progression and Treatment Response.
Cureus. 2024 Jan 5;16(1):e51712. doi: 10.7759/cureus.51712. PMID: 38313884. Review. ˍ




Wang H, Yang J, Li X, Zhao H.
Current state of immune checkpoints therapy for glioblastoma.
Heliyon. 2024 Jan 13;10(2):e24729. doi: 10.1016/j.heliyon.2024.e24729. PMID: 38298707. Review. ˍ




Larangeira Nóbrega AH, Sampaio Pimentel R, Prado AP, Garcia J, Frozza RL, Bernardi A.
Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression.
Curr Cancer Drug Targets. 2024 Jan 17. doi: 10.2174/0115680096265849231031101449. PMID: 38310461. Review˰ ˍ




Yang Z, Sun L, Chen H, Sun C, Xia L.
New progress in the treatment of diffuse midline glioma with H3K27M alteration.
Heliyon. 2024 Jan 18;10(2):e24877. doi: 10.1016/j.heliyon.2024.e24877. PMID: 38312649. Review. ˍ




O'Donovan B, Malone A, Horgan F, Bennett K.
A scoping review protocol of the rehabilitation needs of people with brain tumours.
HRB Open Res. 2024 Jan 29;6:45. doi: 10.12688/hrbopenres.13773.2. PMID: 38304095. Review protocol. ˍ




Abdullaeva S, Chubarev V, Valeeva A, Preferanskaya N, Neganova M, Smolyarchuk E, Liu J, Sukocheva O, Samsonov M, Alyautdin R.
Analysis of Clinical Success and Molecular Mechanisms of Action of Novel Anti-glioblastoma Drugs: A Review.
Curr Med Chem. 2024 Jan 30. doi: 10.2174/0109298673281283240101053940. PMID: 38299393. Review˰ ˍ




Nabavizadeh A.
Introduction to the Special Issue on "Role of Novel Imaging Technique in Brain Tumors".
Cancers (Basel). 2024 Jan 30;16(3):575. doi: 10.3390/cancers16030575. PMID: 38339326. Editorial. ˍ




Sabeghi P, Zarand P, Zargham S, Golestany B, Shariat A, Chang M, Yang E, Rajagopalan P, Phung DC, Gholamrezanezhad A.
Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors.
Cancers (Basel). 2024 Jan 30;16(3):576. doi: 10.3390/cancers16030576. PMID: 38339327. Review. ˍ




Jung AY.
Basics for Pediatric Brain Tumor Imaging: Techniques and Protocol Recommendations.
Brain Tumor Res Treat. 2024 Jan 31;12(1):1-13. doi: 10.14791/btrt.2023.0037. PMID: 38317484. Review, Guidelines. ˍ




Kowalczyk A, Zarychta J, Marszołek A, Zawitkowska J, Lejman M.
Chimeric Antigen Receptor T Cell and Chimeric Antigen Receptor NK Cell Therapy in Pediatric and Adult High-Grade Glioma - Recent Advances.
Cancers (Basel). 2024 Jan 31;16(3):623. doi: 10.3390/cancers16030623. PMID: 38339374. Review. ˍ








Tiefenbach J, Lu VM, Metzler AR, Palejwala A, Haider S, Ivan ME, Komotar RJ, Shah AH.
The use of advanced neuroimaging modalities in the evaluation of low-grade glioma in adults: a literature review.
Neurosurg Focus. 2024 Feb;56(2):E3. doi: 10.3171/2023.11.FOCUS23649. PMID: 38301240. Review. ˍ




Ajithkumar T, Avanzo M, Yorke E, Tsang DS, Milano MT, Olch AJ, Merchant TE, Dieckmann K, Mahajan A, Fuji H, Paulino AC, Timmermann B, Marks LB, Bentzen SM, Jackson A, Constine LS.
PENTEC Organ-Specific Report: Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review.
Int J Radiat Oncol Biol Phys. 2024 Feb 1:S0360-3016(24)00001-4. doi: 10.1016/j.ijrobp.2023.12.043. PMID: 38300187. Review˰ ˍ




Cuschieri A, Pisani R, Agius S.
From Trauma to Tumour: exploring post-TBI glioblastoma patient characteristics.
World Neurosurg. 2024 Feb 1:S1878-8750(24)00144-X. doi: 10.1016/j.wneu.2024.01.122. PMID: 38307194. Review˰ ˍ




McFaline-Figueroa JR.
Spinal Cord Neoplasms.
Continuum (Minneap Minn). 2024 Feb 1;30(1):99-118. doi: 10.1212/CON.0000000000001375. PMID: 38330474. Review˰ ˍ




*Doniselli FM, Pascuzzo R, Mazzi F, Padelli F, Moscatelli M, Akinci D'Antonoli T, Cuocolo R, Aquino D, Cuccarini V, Sconfienza LM.
Quality assessment of the MRI-radiomics studies for MGMT promoter methylation prediction in glioma: a systematic review and meta-analysis.
Eur Radiol. 2024 Feb 3. doi: 10.1007/s00330-024-10594-x. PMID: 38308012. Review, Meta-analysis. ˍ




Sferruzza G, Consoli S, Dono F, Evangelista G, Giugno A, Pronello E, Rollo E, Romozzi M, Rossi L, Pensato U.
A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives.
Neurol Sci. 2024 Feb 3. doi: 10.1007/s10072-024-07350-w. PMID: 38308708. Review˰ ˍ




Huang M, Li S, Li P, Kang Z, Zhang B, Li W.
Drug clinical trials on high-grade gliomas: challenges and hopes.
Cancer Biol Med. 2024 Feb 5;20(12):j.issn.2095-3941.2023.0364. doi: 10.20892/j.issn.2095-3941.2023.0364. PMID: 38318805. Editorial. ˍ




Cooper BT, Mayo CS, Milano MT, Olch AJ, Oh C, Keating GF, Hallstrom A, Constine LS, Laack NN.
Predictive Factors Associated With Radiation Myelopathy in Pediatric Patients With Cancer: A PENTEC Comprehensive Review.
Int J Radiat Oncol Biol Phys. 2024 Feb 6:S0360-3016(23)08256-1. doi: 10.1016/j.ijrobp.2023.12.020. PMID: 38323945. Review˰ ˍ




Wamelink IJHG, Azizova A, Booth TC, Mutsaerts HJMM, Ogunleye A, Mankad K, Petr J, Barkhof F, Keil VC.
Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy?
Radiology. 2024 Feb 6;310(2):e230793. doi: 10.1148/radiol.230793. PMID: 38319162. Review˰ ˍ




Xu F, Yang YH, Yang H, Li W, Hao Y, Zhang S, Zhang YZ, Cao WX, Li XX, Du GH, Ji TF, Wang JH.
Progress of studies on natural products for glioblastoma therapy.
J Asian Nat Prod Res. 2024 Feb 6:1-23. doi: 10.1080/10286020.2023.2300367. PMID: 38321773. Review˰ ˍ




Bali B, Sellers A, Chinea A, Jallo GI, Shimony N.
Intramedullary spinal cord tumors in pediatric patients presenting later with brain lesions: case series and systematic review of the literature.
Childs Nerv Syst. 2024 Feb 7. doi: 10.1007/s00381-024-06311-0. PMID: 38321255. Case report, Review˰ ˍ




Virtanen PS, Ortiz KJ, Patel A, Blocher WA 3rd, Richardson AM.
Blood-Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade.
Curr Oncol Rep. 2024 Feb 8. doi: 10.1007/s11912-024-01497-7. PMID: 38329660. Review˰ ˍ




Cohen KJ, et al, PDQ Pediatric Treatment Editorial Board.
Childhood Ependymoma Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2024 Feb 9. NCBI Bookshelf ID: NBK65935. PMID: 26389373. Review. ˍ




Moreira DC, Bouffet E, Qaddoumi I.
The greatest challenge for pediatric low-grade glioma.
Neuro Oncol. 2024 Feb 10:noae004. doi: 10.1093/neuonc/noae004. PMID: 38339843. Letter. ˍ
Related article:
Fangusaro J, Jones DT, Packer RJ, Gutmann DH, Milde T, Witt O, Mueller S, Fisher MJ, Hansford JR, Tabori U, Hargrave D, Bandopadhayay P.
Pediatric low-grade glioma: State-of-the-art and ongoing challenges.
Neuro Oncol. 2023 Nov 7:noad195. doi: 10.1093/neuonc/noad195. PMID: 37944912. Review. ˍ




Habibi MA, Mirjani MS, Ahmadvand MH, Delbari P, Alasti O.
The safety and efficacy of dabrafenib and trametinib in patients with glioma: A systematic review and meta-analysis.
Eur J Clin Pharmacol. 2024 Feb 12. doi: 10.1007/s00228-024-03635-3. PMID: 38345637. Review, Meta-analysis˰ ˍ




Kudruk S, Forsyth CM, Dion MZ, Hedlund Orbeck JK, Luo J, Klein RS, Kim AH, Heimberger AB, Mirkin CA, Stegh AH, Artzi N.
Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy.
Proc Natl Acad Sci U S A. 2024 Feb 12;121(8):e2306973121. doi: 10.1073/pnas.2306973121. PMID: 38346200. Perspective˰ ˍ




Regmi M, Wang Y, Liu W, Dai Y, Liu S, Ma K, Lin G, Yang J, Liu H, Wu J, Yang C.
From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review.
J Exp Clin Cancer Res. 2024 Feb 12;43(1):47. doi: 10.1186/s13046-024-02973-5. PMID: 38342925. Review. ˍ




Watanabe G, Wong JM, Estes B, Khan MF, Ogasawara C, Umana GE, Martin AR, Bloch O, Palmisciano P.
Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review.
J Neurooncol. 2024 Feb 12. doi: 10.1007/s11060-024-04584-8. PMID: 38342826. Review˰ ˍ




Mirian C, Thastrup M, Mathiasen R, Schmiegelow K, Olsen JV, Østergaard O.
Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.
Fluids Barriers CNS. 2024 Feb 13;21(1):14. doi: 10.1186/s12987-024-00515-x. PMID: 38350915. Review. ˍ




Wagner MW, Jabehdar Maralani P, Bennett J, Nobre L, Lim-Fat MJ, Dirks P, Laughlin S, Tabori U, Ramaswamy V, Hawkins C, Ertl-Wagner BB.
Brain Tumor Imaging in Adolescents and Young Adults: 2021 WHO Updates for Molecular-based Tumor Types.
Radiology. 2024 Feb 13;310(2):e230777. doi: 10.1148/radiol.230777. PMID: 38349246. Review. ˍ




Xing Y, Yasinjan F, Cui J, Peng Y, He M, Liu W, Hong X.
Advancements and current trends in tumor treating fields: a scientometric analysis.
Int J Surg. 2024 Feb 13. doi: 10.1097/JS9.0000000000001151. PMID: 38349201. Bibliographic analysis. ˍ




Furnari FB, Anastasaki C, Bian S, Fine HA, Koga T, Le LQ, Rodriguez FJ, Gutmann DH.
Stem cell modeling of nervous system tumors.
Dis Model Mech. 2024 Feb 14;17(2):dmm050533. doi: 10.1242/dmm.050533. PMID: 38353122. Review. ˍ




Newton HB, Wojkowski J.
Antiepileptic Strategies for Patients with Primary and Metastatic Brain Tumors.
Curr Treat Options Oncol. 2024 Feb 14. doi: 10.1007/s11864-024-01182-8. PMID: 38353859. Review. ˍ